Skip to main navigation Skip to search Skip to main content

Clinical Features, Socioeconomic Status, Management, and Outcomes oAcute Heart Failure: PEACE MENA Registry Phase I Results

  • Hanan Albackr
  • , Khalid F. Alhabib
  • , Kadhim Sulaiman
  • , Amal Jamee
  • , Mohamed Sobhy
  • , Salim Benkhedda
  • , Sobhi Dada
  • , Ayman Hammoudeh
  • , Habib Gamra
  • , Ahmed Al-Motarreb
  • , Fahad Alkindi
  • , Mohammad I. Amin
  • , Magdi G. Yousif
  • , Hasan A. Farhan
  • , Nadia Fellat
  • , Wael Almahmeed
  • , Mohammad Al Jarallah
  • , Prashanth Panduranga
  • , Magdy Abdelhamid
  • , Ihab Ghaly
  • Dahlia Djermane, Ahcene Chibane, Hadi Skouri, Mohamad Jarrah, Hassen Amor, Nora K. Alsagheer, Mohammed A. Hozayen, Hosameldin S. Ahmed, Muhammad Ali, Anhar Ullah, Ayman Al Saleh, Faiez Zannad
  • King Saud University
  • Royal Hospital Oman
  • Ministry of Health Palestine
  • International Cardiac Center (ICC)
  • Benyoucef Benkhedda University
  • Hammoud Hospital
  • Istishari Hospital, Amman
  • University of Monastir
  • Sanaa University
  • Hamad Medical Corporation
  • Mohamed Bin Khalifa Cardiac Centre
  • Sudan Heart Centre
  • Ministry of Higher Education and Scientific Research
  • Ibn Sina Hospital, Agdal Rabat
  • Sabah Al-Ahmed Cardiac Center
  • Cairo University
  • Alhyatt Heart and Vascular Center
  • University of Algiers Benyoucef Benkhedda
  • American University of Beirut
  • Jordan University of Science and Technology
  • Taher Sfar University Hospital
  • Arass General Hospital
  • Saudi Heart Association
  • Imperial College London
  • Université de Lorraine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Introduction: PEACE MENA (Program for the Evaluation and Management of Cardiac Events in the Middle East and North Africa) is a prospective registry in Arab countries for in-patients with acute myocardial infarction (AMI) or acute heart failure (AHF). Here, we report the baseline characteristics and outcomes of in-patients with AHF who were enrolled during the first 14 months of the recruitment phase. Methods: A prospective, multi-centre, multi-country study including patients hospitalized with AHF was conducted. Clinical characteristics, echocardiogram, BNP (B-type natriuretic peptide), socioeconomic status, management, 1-month, and 1-year outcomes are reported Results: Between April 2019 and June 2020, a total of 1258 adults with AHF from 16 Arab countries were recruited. Their mean age was 63.3 (±15) years, 56.8% were men, 65% had monthly income ≤US$ 500, and 56% had limited education. Furthermore, 55% had diabetes mellitus, 67% had hyperten-sion; 55% had HFrEF (heart failure with reduced ejection fraction), and 19% had HFpEF (heart failure with preserved ejection fraction). At 1 year, 3.6% had a heart failure-related device (0-22%) and 7.3% used an angiotensin receptor neprilysin inhibitor (0-43%). Mortality was 4.4% per 1 month and 11.77% per 1-year post-discharge. Compared with higher-income patients, lower-income patients had a higher 1-year total heart failure hospitalization rate (45.6 vs 29.9%, p=0.001), and the 1-year mortality difference was not statistically significant (13.2 vs 8.8%, p=0.059). Conclusion: Most of the patients with AHF in Arab countries had a high burden of cardiac risk factors, low income, and low education status with great heterogeneity in key performance indicators of AHF management among Arab countries.

Original languageEnglish
Pages (from-to)257-267
Number of pages11
JournalCurrent Vascular Pharmacology
Volume21
Issue number4
DOIs
StatePublished - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AHF
  • Acute heart failure
  • HFrEF
  • Middle East
  • North Africa
  • PEACE MENA

Fingerprint

Dive into the research topics of 'Clinical Features, Socioeconomic Status, Management, and Outcomes oAcute Heart Failure: PEACE MENA Registry Phase I Results'. Together they form a unique fingerprint.

Cite this